Speakers

International Invited Speakers

	Peter Ellis Associate Professor Peter Ellis MBBS MMed(Clin Epi) PhD FRACP FRCPC Dr Ellis is an Associate Professor in the Departments of Oncology and Clinical Epidemiology & Biostatistics at McMaster University. He is also a staff medical oncologist at the Juravinski Cancer Centre (JCC). He obtained his medical degree at the University of Sydney. He completed a Masters of Medicine (Clinical Epidemiology) and a Doctor of Philosophy also at the University of Sydney. Associate Professor Ellis moved to Canada in October, 2000. He is the Chair of the JCC Lung Disease Site Team, an Executive Member of the National Cancer Institute of Canada (NCIC) Clinical Trials Group Lung Disease Site Committee, and is a member of Cancer Care Ontario's Practice Guideline Initiative, Provincial Lung Disease Site Group. He is also an investigator on several NCIC and pharmaceutical industry-sponsored multicentre phase III clinical trials in breast and lung cancer.
	David Quinn Associate Professor David Ian Quinn MBBS Honors Class 1, PhD, FRACP is an international expert in the field of clinical trials and molecular correlative studies in genitourinary cancer. Dr. Quinn is the Medical Director of the Norris Cancer Hospital and clinics, Leader of the Developmental Therapeutics Program for the Norris Comprehensive Cancer Center, Head, Section of Genitourinary Medical Oncology and Associate Professor of Medicine in the Division of Cancer Medicine and Blood Diseases, Keck School of Medicine, University of Southern California He has published more than 100 papers, reviews and chapters and is a reviewer for more than 20 peer-reviewed journals, is on the editorial boards of American Journal of Clinical Oncology and cancer.net (American Society of Clinical Oncology) and is a full member of the National Cancer Institute' Subcommittee H review panel for the North American Cooperative groups. He has been an invited speaker in more than 30 countries.
	Roman Perez-Soler Associate Director of Clinical Oncology, Dr. Roman Perez-Soler serves as associate director of clinical oncology at the New York University Medical Center, Kaplan Cancer Center. In addition to his positing at NYU, Dr. Perez-Soler also serves as the Chairman of Clinical Oncology at the Montefiore Medical Center, Director of the Division of Medical Oncology at the Albert Einstein College of Medicine, and Professor of Medicine and Molecular Pharmacology at Albert Einstein Dr. Perez-Soler received his early medical training in Spain, earning his medical degree from Universidad Autonoma of Barcelona in 1977. He also completed his residency in internal medicine in 1982, also at Universidad Autonoma. He came to the United States in 1982 and completed a fellowship in medical oncology at the University of Texas M.D. Anderson Cancer Center in 1985. He received board certifications in internal medicine and medical oncology in 1987 and 1989, respectively. Dr. Perez-Soler serves as member of the Executive Advisory Committee of the General Clinical Research. He is a member of many professional organizations and has received peer acclaim and awards for his work in lung cancer treatment and research. He is published in over a hundred studies, papers, and articles.

Local Invited Speakers

	Sanchia Aranda Professor Aranda holds a joint appointment as Director of Cancer Nursing Research at the Peter MacCallum Cancer Centre and Head, the Department of Nursing, School of Health Sciences, The University of Melbourne. Her research program centres on cancer supportive care where she works with a multidisciplinary team of researchers to develop and test novel interventions to improve patient outcomes. She has conducted randomised controlled trials of interventions to reduce pain, fatigue, distress associated with advanced breast cancer and chemotherapy related concerns. She is currently working on projects involving the use of mobile phones in symptom monitoring and in use of web 2 social networking tools to facilitate cancer shared care. She is President of the International Society of Nurses in Cancer Care, is a member of the Cancer Australia Advisory Council and is a member of the Victorian Cancer Action Plan Implementation Committee.
	Professor Jim Bishop AO Professor James Bishop AO is Chief Medical Officer for the Australian Government and is the principal medical adviser to the Minister and the Department of Health and Ageing. He plays a key, strategic role in developing and administering major health reforms for all Australians. In particular his close association with Australia’s medical fraternities and researchers will be crucial in the development of evidence based public health policy. Prior to his appointment Professor Bishop was a Professor of Cancer Medicine at the University of Sydney, Fellow of the Royal Australasian College of Physicians (FRACP) and a Fellow of the Royal College of Pathologists of Australasia (FRCPA) in haematology. He was awarded a Doctorate of Medicine by research thesis (Platelet Transfusion Therapy) in 1990 and a Master of Medicine by research thesis (Induction Therapy for Acute Myeloid Leukaemia) in 1999. Professor Bishop was awarded a Fulbright Scholarship to study medical oncology at the National Cancer Institute (NCI), USA from 1979 to 1981 and from 1981 to 1995 he was a consultant medical oncologist at the Peter MacCallum Cancer Institute in Melbourne. From 1995 to 2003, Professor Bishop was the Director of the Sydney Cancer Centre at the Royal Prince Alfred Hospital and Concord Hospital in Sydney and he also directed the Cancer Service for the Central Sydney Area Health Service. From 2003 to April 2009 he was the CEO of the Cancer Institute NSW and the Chief Cancer Officer for NSW. In 2008 Professor Bishop was made an Officer of the Order of Australia (AO) for service to medicine, particularly in the field of cancer treatment and research.
	Phyllis Butow Professor Phyllis Butow has worked for over 20 years in the areas of Psycho-Oncology and health communication. She is currently Professor and NHMRC Principal Research Fellow in the School of Psychology, University of Sydney. She co-directs the Centre for Medical Psychology and Evidence-based Decision-making (CeMPED) and chairs the Australian Psycho-Oncology Co-operative Trials Group (PoCoG). Much of her research concerns communication between doctors, family members and patients, and this has been translated into a number of resources and communication skills modules for cancer health professionals. Her work is also featured in the Australian Psychosocial Clinical Practice Guidelines for Adults with Cancer. Since 1995, Professor Butow has won 81 peer reviewed grants, and has over 250 publications in peer reviewed journals, most of which relate to psychological issues in cancer. In 2009, Professor Butow was awarded the Bernard Fox Memorial Award by the International Psycho-Oncology Society in recognition of an outstanding contribution to the field of Psycho-Oncology.
	Stephen Clarke Professor Stephen Clarke is a Medical Oncologist and Clinical Pharmacologist and is currently Professor and Head of the Discipline of Medicine at the Concord Hospital Clinical School of the University of Sydney. He obtained an MBBS from Sydney University in 1983 and then undertook specialty training in Medical Oncology, obtaining a Fellowship from the RACP in 1990. Between 1991 and 1993, he was a research fellow at the Royal Marsden Cancer Hospital and the Institute of Cancer Research in Sutton, Surrey, UK, gaining his PhD through the University of London. He has research interests in mesothelioma, colorectal and lung cancer.
	Professor David Currow Professor David Currow is currently the Chief Executive Officer of the Cancer Institute, New South Wales and Chief Cancer Officer for this State. He has previously had the role of foundation Chief Executive Officer of Cancer Australia, the Australian government's national cancer control agency. He continues to hold the appointment of Professor of Palliative and Supportive Services at Flinders University, Adelaide, South Australia.
	Jon Emery Professor Jon Emery is the Professor of General Practice at UWA and a Senior Clinical Research Associate at the University of Cambridge. He chairs the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4). He leads collaborative programmes of research based in Australia and the UK with a focus on diagnosis and management of cancer in primary care, and the application of genetic medicine in primary care.
	Paul Grogan Mr Paul Grogan is Director of Advocacy at Cancer Council Australia, where for the past six years he has been responsible for promoting cancer control policy at the national level across the spectrum from primary prevention through to patient support. Before joining Cancer Council, Paul worked for more than 10 years as a media and policy adviser to several federal and state government organisations, particularly in the area of parliamentary liaison where he gained a professional understanding of how government policy is developed and implemented.
	Michael Jefford Associate Professor Michael Jefford is a consultant medical oncologist at Peter MacCallum Cancer Centre, Clinical Consultant with the Cancer Information and Support Service (a unit of Cancer Council Victoria) and is a Principal Fellow with the University of Melbourne. He is Director of the newly established Australian Cancer Survivorship Centre. He holds a PhD and also Masters degrees in Public Health and in Health Services Management. His clinical practice, and part of his clinical research, focuses on the management of people with gastrointestinal cancers. He also has extensive experience designing interventions to improve the psychological wellbeing and supportive care outcomes of people affected by cancer. He has published 70 peer-reviewed manuscripts and has presented work at several international meetings covering cancer control, clinical oncology and psycho-oncology.
	Bogda Koczwara Associate Professor Bogda Koczwara is a medical oncologist and the Director of Cancer Services for the Southern Adelaide Health Service. Her clinical interests revolve around management of breast cancer, in particular in young women, psychooncology and supportive care and she has a particular interest in strengthening of the interface between specialist and primary care for cancer patients especially in rural Australia. Professor Koczwara is the President Elect of the Clinical Oncology Society of Australia (COSA) and the Immediate Past Chairman of the Medical Oncology Group of Australia. She is the immediate past Chair the Australia Asia Pacific Clinical Oncology Research Development, a collaborative of international cancer organisations aimed at improving cancer research capacity in Australia and Asia Pacific. Professor Koczwara chairs the COSA Complementary Care Collaborative and serves on the advisory panel for the National Institute of Complementary Medicine. She serves as the regional representative for Australia and Pacific to the European Society of Medical Oncology (ESMO) and is a member of the ESMO Ethics Committee.
	Matthew Links Associate Professor Matthew Links is a medical oncologist at St George and Sutherland Hospital with a longstanding interest in innovation for medical education. He has been involved in eviQ from its early days and is currently the Director of the eviQEd program of online education. He also is the co-ordinator of medical oncology training for South Eastern Sydney Illawarra Area Health service. Education interests include online learning and new approaches to assessment.
	Grant McArthur Associate Professor Grant McArthur is Head of the Cancer Therapeutics Program, Molecular Oncology and Translational Research Laboratories, and the Medical Oncology Skin and Melanoma Clinical Service at Peter MacCallum Cancer Centre, Melbourne. He is a Fellow of the RACP, and holds a PhD in Medical Biology. Research interests include, clinical trials of targeted therapeutics, molecular profiling of cancer, melanoma, cell cycle control, differentiation, and functional imaging. The focus of his research has evolved from purely research based to linking an understanding of the basic cellular mechanisms of cancer to the development and application of novel targeted cancer therapeutics. He achieves this by linking the activities of the two laboratories and early phase clinical trials as well as leading major collaborative groups.
	Elizabeth McCaffrey Dr Elizabeth McCaffrey attained her MBBS from the University of Queensland in 1995 and completed the FRACP in Medical Oncology in 2003. She currently works at the Department of Medical Oncology at the Princess Alexandra Hospital and has particular interests in lung, prostate and breast cancer.
	Ian Olver Professor Ian Olver is a medical oncologist and currently Chief Executive Officer of the Cancer Council Australia and Clinical Professor in the Sydney Medical School, University of Sydney. He graduated from the University of Melbourne in 1976, completed an MD in 1991 on clinical trial methodology and a PhD from Monash University in bioethics in 1997. He sits on the Advisory Board of Cancer Australia and chairs the Board on the National Breast and Ovarian Cancer Centre. He sits on the NHMRC Ethics Committee and its Preventive and Community Health Committee. He has published over 180 articles in journals, 16 book chapters and written 2 and edited 3 books.
	Professor Ronald Penny AO Professor Ronald Penny AO is one of Australia’s leading immunologists and is currently Emeritus Professor of Medicine, University of NSW; and Senior Clinical Advisor, NSW Health. He was Director, Centre for Immunology at St Vincent’s Hospital and University of NSW until 2002. He is currently the Co-Chair of the NSW Chronic Aged Community Health Priority Taskforce. Professor Penny was in 1979 awarded the first Doctor of Science for clinical research from the University of NSW, followed by a Personal Chair in clinical immunology in 1998. Professor Penny has published over 350 medical and scientific papers in prestigious national and international journals. Professor Penny was previously the Co-Chair the NSW State Government's Chronic and Complex Care Implementation Advisory Group; Chairman of the NSW Blood Products Advisory Committee; Chairman of the NSW SARS Task Force, and the Ministerial Advisory Council on Medical and Health Research. Professor Penny has served as Honorary Consultant at many Sydney hospitals and was a member of the Editorial Boards of a number of leading international journals. He is a Director of Cryosite Pty Ltd, is an advisor to Peptech Ltd, the Medical Director of Good Health Solutions, and a Director of Pro-Biomics.
	Professor Sally Redman Professor Redman is CEO of the Sax Institute. The Sax Institute is funded by NSW Health to increase the impact of public health and health services research on policy and practice. It is responsible for the 45 and Up Study, Australia’s largest study on health and ageing, major programs in Aboriginal health, and has developed innovative approaches to increasing the use of evidence by policy agencies. Professor Redman was previously the inaugural Director of the National Breast Cancer Centre, funded by Australia's federal government to improve evidence-based care & outcomes for women with breast cancer. She received the Centenary Medal, for service to the health and welfare of Australian women diagnosed with breast cancer, 2003. Professor Redman is a public health researcher with an interest in evaluating programs designed to improve health and health care. She has over 150 publications in peer review journals.
	Gary Richardson Associate Professor Gary Richardson is currently the Director of Academic Cancer Services at Cabrini Health, and Associate Professor of Medicine at Monash University. Prior to this he held the position of Director of the Department of Medical Oncology & Clinical Haematology, Monash Medical Centre. He trained at St Vincent's Hospital (Melbourne), the Peter MacCallum Cancer Institute, and the National Cancer Institute Naval Oncology Branch in Maryland USA. He has extensively published in the field of lung cancer. His major interests include breast cancer, gynaecologic oncology, lung cancer, non-Hodgkin's lymphoma, and targeted therapies.
	Eva Segelov Associate Professor Eva Segelov - MBBS (Hons 1), PHD, FRACP is a Medical Oncologist at St Vincent's Hospital, St Vincent 's Private Hospital and St Vincent's Clinic. She is a clinical academic at the University of New South Wales. Her predominant interests are in GI and breast oncology, and she is Chair of the GI Group of COSA (Clinical Oncological Society of Australia). Eva convened the COSA ASM in 2008 and 2009, and is again convenor this year for the meeting in Melbourne in November, which promises to be the largest and most comprehensive multidisciplinary cancer professionals meeting in Australia. The meeting will be preceded by a trainee workshop “Everything you need to know about breast cancer". Eva is actively involved in clinical trials and has been the principal investigator for AGITG on the QUASAR 2 study of adjuvant bevacizumab with capecitabine in colorectal cancer, and is co-PI on the AGITG SCOT study evaluating 3 v 6 months of adjuvant chemotherapy for Stage III colon cancer. She is also involved with the development of EDV(R) minicell therapy currently in Phase 1 clinical trials. Her other interest is in medical education and new techniques to enhance adult learning.
	John Simes Professor John Simes is currently a Senior Principal Research Fellow and Founding Director of the NHMRC Clinical Trials Centre, University of Sydney. He practices as a medical oncologist at the Royal Prince Alfred Hospital, and is a leading international researcher in clinical trials, particularly clinical trials in cancer, cardiovascular disease, diabetes and neonatal medicine. His research interests include clinical trials methodology, quality of life assessment and integrating trial evidence with the goal of improving clinical practice and health outcomes as well as developing better methods for combining trial evidence. As Professor of Clinical Epidemiology at the Faculty of Medicine, University of Sydney, he teaches decision analysis and its use in cost-effectiveness analysis in the Master of Public Health and Clinical Epidemiology courses. He recently received the Harvard Alum award (Biostatistics), Harvard University (2009) in recognition of some of this work.
	Andrew Simpson Mr Andrew Simpson spent the best part of a decade working as an adviser to the Federal Government. During this time he worked in a number of portfolios including a 4 year stint as adviser to \then Minister for Health & Ageing Tony Abbott. In this role he was responsible for oversighting the development and implementation of the 2004 election policy, Strengthening Cancer Care that saw nearly $200 million in additional funding for cancer control. Currently, he works as a consultant in government relations, stakeholder issues and media management.
	Paul de Souza Dr. Paul de Souza is a Senior Staff specialist in the Department of Medical Oncology at the St George and Sutherland Hospitals in Sydney. Dr de Souza is a member of the MOGA Executive Committee and the Special Advisory Board-Medical Oncology with the RACP. He has an interest in translational research, drug development, urological cancers, and clinical trials.
	Daniel Thurley Dr Daniel Thurley is Associate Medical Director (Oncology/Haematology) for Roche Products, Australia and Honorary Clinical Fellow - Oncology, at The Royal North Shore Hospital, Sydney. Having begun higher medical training in Medical Oncology in the UK, Dan completed specialist training in Pharmaceutical Medicine, and is Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians, UK. Dan has worked in both national and international medical roles within several pharmaceutical companies and has particular interests in early phase clinical trials and also the applications and implications of the internet for healthcare.
	Craig Underhill Dr Craig Underhill is a Medical Oncologist in the regional city of Albury-Wodonga and is the Clinical Director for cancer services in a region encompassing southern NSW and north eastern Victoria. Services collaborate in a unique cross border clinical network. He is the former chair of the regional and rural group of COSA. He is an avid participant in health services research as well as clinical research activities.
	Robyn Ward Professor Robyn Ward is the Clinical Associate Dean Prince of Wales Clinical School, University of NSW and the Director of Area Cancer Services for the South East Sydney Illawarra Area Health Service. She is a specialist medical oncologist at Prince of Wales Hospital, Sydney and holds a PhD in medicine. She leads the Adult cancer research program in the Lowy cancer centre which is focused on the application of recent advances in molecular biology to the clinical problem of cancer. She was awarded the Commonwealth Health Minister's Award for Excellence in Health and Medical Research in 2004, and the Premiers Award for Outstanding Cancer Researcher in 2007. Amongst other roles, Professor Ward serves as member of the Commonwealth's Pharmaceutical Benefits Advisory Committee and in 2009 she was appointed the Chair of the Medical Services Advisory Committee.
	Paul Waring Professor Paul Waring trained as an anatomical pathologist at the QEII Medical Centre in Perth, undertook a PhD at the Walter and Eliza Hall Institute and a post - doctoral fellowship in Molecular Pathology at Stanford University. His past appointments include: Director of Pathology at the Peter MacCallum Cancer Centre (2001-04), Sr. Director of Pathology and Diagnostics at Genentech Inc, USA (2004-2008). He was recently appointed as Chair in Pathology at The University of Melbourne. His current interests include the use of biomarkers to select patients for new targeted anti-cancer therapies. He has published 60 peer - reviewed articles.